← FDA DRUG APPROVALS

FDA ANDA · ANDA065079

PENICILLIN G POTASSIUM

Sponsor: SANDOZ

APPLICATION
ANDA065079
TYPE
ANDA
ORIGINAL APPROVAL
2002-08-30
LATEST ACTION
2004-09-30
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription, Discontinued

Products

PENICILLIN G POTASSIUMPrescription
PENICILLIN G POTASSIUM 20,000,000 UNITS/VIAL · INJECTABLE · INJECTION
PENICILLIN G POTASSIUMDiscontinued
PENICILLIN G POTASSIUM 1,000,000 UNITS/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION
PENICILLIN G POTASSIUMPrescription
PENICILLIN G POTASSIUM 5,000,000 UNITS/VIAL · INJECTABLE · INJECTION

Approval history

2004-09-30Labeling · Supplement 4AP
2002-08-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →